Minds + Assembly, a 2024 MM+M Agency 100 honoree, added Chuck Hemann as chief integration officer and Jonathan Woodring as ...

Robert F. Kennedy Jr. defended his prior public statements on a range of health policy issues in a fiery confirmation hearing ...

Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...

The best office chair offers better ergonomics, all-day comfort, lumbar support, and smart designs to suit every workspace. My team and I tested over 50 different desk chairs, including task ...

UTA Health Services is accredited through October 11, 2026. The health center lab maintains accreditation by the Commission of Office Laboratory Accreditation (COLA), the premier clinical laboratory ...

Can't decide between Microsoft 365 or Office 2024 for school or work? In this guide, we'll help you pick the best option for you. When you purchase through links on our site, we may earn an ...

A Northeast Ohio doctor’s office is working on a new vaccine that ... Dr. Senders and the research team at Senders Pediatrics are working with Moderna on a new MRNA vaccine that seeks to wipe ...

Moderna fell to a new 52-week low after some disappointing news. The short explanation is that demand for Moderna's COVID-19 vaccine has plunged since the end of the pandemic. Moderna still has ...

Moderna has lowered 2025 revenue guidance after a tough 2024 coronavirus vaccination season. However, the company aims to launch 10 new products over the next few years -- and that could lead to ...

Ratings for Moderna MRNA were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings ...

A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.

There are currently three vaccine candidates moving through the clinical pipeline in human trials right now, and the furthest along is Moderna, which has developed a norovirus vaccine with the ...